Novavax began its late-stage COVID-19 vaccine trial. The company began a phase 3 trial in the U.K. and expects to launch a U.S. trial next month. Novavax is slightly behind competitors, some of which have already begun phase 3 trials, but early studies showed promising results for its experimental vaccine. (The New York Times)
Pharmacies brace for a surge in demand for the flu vaccine. Companies like Rite Aid and Walgreens are purchasing more flu shots in anticipation of more people getting the vaccine this year. (STAT)
Join us for the inaugural MM+M 40 Under 40 event on September 29. Join the virtual event for the 40 Under 40 awards, networking and panels. (MM+M)
Our virtual conference MM+M Transform is September 30 to October 1. Speakers include marketing leaders from pharma, the Food and Drug Administration, social media platforms, agencies and health nonprofits. (MM+M)
The virtual MM+M Awards will be held October 8. Find out who this year’s winners are and celebrate the best work in the industry in a new virtual experience. (MM+M)
